BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours
NCT01145885
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
7
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
BI 6727
Sponsor
Boehringer Ingelheim